EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Central nervous system infection following allogeneic hematopoietic stem cell transplantation

Ryo Hanajiri, Takeshi Kobayashi, Kosuke Yoshioka, Daisuke Watanabe, Kyoko Watakabe, Yutaka Murata, Takeshi Hagino, Yasushi Seno, Yuho Najima, Aiko Igarashi, Noriko Doki, Kazuhiko Kakihana und 2 weitere

Hematology/Oncology and Stem Cell Therapy · 2017-01 · 10 (1) · 22-28

DOI: 10.1016/j.hemonc.2016.08.008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hematology/Oncology and Stem Cell Therapy, 2017-01. Verfasst von Ryo Hanajiri und 13 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective/background: Here, we described the clinical characteristics and outcomes of central nervous system (CNS) infections occurring after allogeneic hematopoietic stem cell transplantation (allo-HSCT) in a single institution over the previous 6 years.

Methods

Charts of 353 consecutive allogeneic transplant recipients were retrospectively reviewed for CNS infection.

Results

A total of 17 cases of CNS infection were identified at a median of 38 days (range, 10– 1028 days) after allo-HSCT. Causative pathogens were human herpesvirus-6 ( n = 6), enterococcus ( n = 2), staphylococcus ( n = 2), streptococcus ( n = 2), varicella zoster virus ( n = 1), cytomegalovirus ( n = 1), John Cunningham virus ( n = 1), adenovirus ( n = 1), and Toxoplasma gondii ( n = 1). The cumulative incidence of CNS infection was 4.1% at 1 year and 5.5% at 5 years.

Conclusion

Multivariate analysis revealed that high-risk disease status was a risk factor for developing CNS infection ( p = .02), and that overall survival at 3 years after allo-HSCT was 33% in patients with CNS infection and 53% in those without CNS infection ( p = .04).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationAdolescentAdultAgedBacterial InfectionsCentral Nervous System InfectionsCytomegalovirusFemaleHerpesvirus 6, HumanHumansIncidenceMaleMiddle AgedMultivariate AnalysisRetrospective StudiesRisk FactorsStaphylococcusSurvival RateTransplantation, HomologousVirus DiseasesYoung Adult

Stichwörter der Autor:innen

Allogeneic hematopoietic stem cell transplantationCentral nervous system infectionsHuman herpesvirus 6

Autor:innen und Institutionen

  • Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan. Electronic address: k.ohashi@cick.jp.

Zitieren

APA

Hanajiri, R., Kobayashi, T., Yoshioka, K., Watanabe, D., Watakabe, K., Murata, Y., Hagino, T., Seno, Y., Najima, Y., Igarashi, A., Doki, N., Kakihana, K., Sakamaki, H., & Ohashi, K. (2017). Central nervous system infection following allogeneic hematopoietic stem cell transplantation. Hematology/Oncology and Stem Cell Therapy, 10(1), 22-28. https://doi.org/10.1016/j.hemonc.2016.08.008

Vancouver

Hanajiri R, Kobayashi T, Yoshioka K, Watanabe D, Watakabe K, Murata Y, et al. Central nervous system infection following allogeneic hematopoietic stem cell transplantation. Hematology/Oncology and Stem Cell Therapy. 2017;10(1):22-28. doi:10.1016/j.hemonc.2016.08.008

BibTeX
@article{Hanajiri2017,
  author = {Hanajiri, Ryo and Kobayashi, Takeshi and Yoshioka, Kosuke and Watanabe, Daisuke and Watakabe, Kyoko and Murata, Yutaka and Hagino, Takeshi and Seno, Yasushi and Najima, Yuho and Igarashi, Aiko and Doki, Noriko and Kakihana, Kazuhiko and Sakamaki, Hisashi and Ohashi, Kazuteru},
  title = {Central nervous system infection following allogeneic hematopoietic stem cell transplantation},
  journal = {Hematology/Oncology and Stem Cell Therapy},
  year = {2017},
  volume = {10},
  number = {1},
  pages = {22--28},
  doi = {10.1016/j.hemonc.2016.08.008}
}
Kostenlos starten →